News Scandinavian ChemoTech AB

Equities

CMOTEC B

SE0009242654

Market Closed - Nasdaq Stockholm Other stock markets 11:29:45 2024-04-17 am EDT			5-day change	1st Jan Change
2.39 ^SEK	-3.24%		+3.91%	-11.48%

Apr. 10	Scandinavian ChemoTech AB Attains Progress by Obtaining Patent Protection for Two Essential Patents in India	CI
Mar. 27	Scandinavian ChemoTech Secures Order from the Largest European Equine Clinic	CI

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

ChemoTech attains progress by obtaining patent protection for two essential patents in India	Apr. 10	AQ
Scandinavian ChemoTech AB Attains Progress by Obtaining Patent Protection for Two Essential Patents in India	Apr. 10	CI
Scandinavian ChemoTech's Animal Care embarks on an exciting journey along with Equitom to forge a cutting-edge Centre of Excellence	Apr. 05	AQ
ChemoTech secures order from the largest European state-of-the-art equine (horse) clinic	Mar. 27	AQ
Scandinavian ChemoTech Secures Order from the Largest European Equine Clinic	Mar. 27	CI
IQwave™ Receives Certification for Tumour Treatment in Singapore	Mar. 25	AQ
Scandinavian ChemoTech AB's IQwave Receives Certification for Tumour Treatment in Singapore	Mar. 25	CI
Scandinavian ChemoTech - Weathering the storm	Mar. 22	AQ
ChemoTech signs new agreement with a private hospital & medical college	Mar. 20	AQ
Scandinavian ChemoTech AB Signs New Agreement with Chhatrapati Shivaji Subharti Hospital & Medical College	Mar. 20	CI
ChemoTech adapts its strategy and short-term targets for Human Care	Mar. 20	AQ
Scandinavian ChemoTech AB (publ) Year-End Report January - December 2023 - Executive Summary	Mar. 05	AQ
Scandinavian ChemoTech AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	Mar. 05	CI
Scandinavian ChemoTech AB Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 05	CI
New order received for the Innovative TSE Cancer Treatment Technology	Feb. 12	AQ
Scandinavian ChemoTech AB Receives Order for USD 30,000 from One of Its Largest Clients in the United States	Feb. 12	CI
Transcript : Scandinavian ChemoTech AB - Special Call	Jan. 29
Invitation to Presentation on the recent Ethics Committee Approval and Clinical Strategy	Jan. 26	AQ
Ground-breaking milestone in Head & Neck cancer treatment achieved	Jan. 26	AQ
Scandinavian ChemoTech Celebrates Year-End Success with insightful TSE Case Reports	Dec. 29	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Scandinavian ChemoTech AB

Equities

CMOTEC B

SE0009242654

Summary

Filters